IT
-
EN
Home
About Us
Our Mission
History
Corporate Structure
Key Financial data
Key Data
Net Sales
Sales by Business
Pharmaceuticals: Net Sales
Key P&L and EBITDA
Balance Sheet Structure
Per Share Data
Management
Contacts
Pharmaceutical Operations
Markets
Products
Benelux
Czech Republic & SlovaKia
France
Germany
Greece
Ireland
Italy
Nordics
Poland
Portugal
Romania
Russia
Spain
Switzerland
Tunisia
Turkey
United Kingdom
Ukraine
R & D
Pipeline
Pubblications
Pharmaceutical Production
Pharmaceutical Chemicals
Products
Production
D.M.F. & C.E.P.
Rare Diseases
Investors
Recordati at a glance
Recordati Share
Key Financial data
Key data
Net Sales
Sales by Business
Pharmaceuticals: Net Sales
Key P&L and EBITDA
Balance Sheet Structure
Per Share Data
News & Announcements
Business & financial news
Other press releases
Announcements
Public Tender Offer
Company Presentations
Annual & Interim Reports
Regulated Information Service Providers
Shareholders' Meetings
Reverse Merger into Recordati S.p.A. 2020/2021
Regulations for Shareholders' Meetings
Calendar
Analyst Coverage
Contacts IR
Internal Dealing
Internal Dealing Regulations
Internal Dealing Press Releases
Corporate Governance
Company by Laws
Board of Directors
Board of Statutory Auditors
Firm of Auditors
Shareholders agreements
In force
Historical Record
Report on Corporate Governance and the Ownership Structure
Remuneration
Remuneration Reports
Stock Option Plans
Share Buy-back
Related Parties
Regulations for Related-Party Transactions
Compliance programmes
Changes in share capital
Other Corporate Documents
Corporate Affairs Contacts
Relevant Information and Inside Information
News & Announcements
Business & financial news
Other press releases
Announcements
Partnering
Our Capabilities
Our Needs
Contacts
Selected Partnerships
Join Us
Training for further development
Internships: start building Your future
Professional Areas
International Presence
News & Announcements
Menu
Business & financial news
Other press releases
Announcements
Recordati
Share
News & Announcements
Business & financial news
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
2021, February 22 - 18:25
RECORDATI: SHARE BUY-BACK PROGRAM TO SERVICE THE STOCK OPTION PLANS
2021, February 22 - 12:58
RECORDATI: PRELIMINARY 2020 RESULTS CONFIRM CONTINUED GROWTH OF OPERATING AND NET INCOME. EBITDA +4.7% AND ADJ NET INCOME +7.3%
2021, January 29 - 18:06
RECORDATI: LICENSE OBTAINED FOR THE COMMERCIALIZATION OF ELIGARD IN EUROPE AND OTHER COUNTRIES
2021, January 26
RECORDATI: CARBAGLU receives U.S. FDA Approval for a New Indication to Treat Acute Hyperammonemia Associated with Propionic Acidemia and Methylmalonic Acidemia
= price sensitive (as from 2015)